One in five Canadian patients deliberately do not take insulin as prescribed to reduce the risk of experiencing low blood sugar at night
TORONTO, Nov. 28, 2012 /CNW/ - More than a quarter of Canadians living with type 2 diabetes are not taking insulin as prescribed by their physician, reveals an international survey. The survey reveals a startling correlation between mis-dosed insulin and incidences of dangerously low blood sugar, known as a hypoglycemic event, as one third of survey respondents also reported experiencing at least one hypoglycemic event over a 30-day period.
The GAPP2™ (Global Attitude of Patients and Physicians) survey shows that Canadian healthcare professionals (HCPs) are concerned that patients often under-report frequency or severity of hypoglycemic events despite reporting that they discussed these events with approximately six in ten patients over a 30-day time period.
Insulin dosing irregularities are common in Canadian patients The GAPP2™ survey revealed that HCPs believe that long acting insulin analogues are better than intermediate acting insulin (neutral protamine Hagedorn or NPH) in providing good blood glucose control and reducing hypoglycemia. However, insulin management still has some challenges which can result in the patients' diabetes not being well controlled:
- Long acting insulin dosing irregularities and self-treated hypoglycemia are common in type 2 diabetes patients who take insulin, and impact on the patients' well-being
- Patients' lives are negatively affected by having to take long acting insulin at the prescribed time, and taking long acting insulin at the same time each day is often inconvenient
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts